Supriya Lifescience Limited
MainboardlistedSUPRIYAINE07RO01027- DRHP filed17 May 21
- RHP filed13 Dec 21
- Open16 Dec 21
- Close20 Dec 21
- Listed28 Dec 21
Issue
- Price band
- ₹265–274
- Issue price
- ₹274
- Face value
- ₹2
- Lot size
- 54
- Issue size
- ₹700 Cr
- Fresh / OFS
- ₹200 Cr / ₹500 Cr
- Issue type
- book built
- Registrar
- Link Intime India Private Limited
- Exchanges
- BSE, NSE
- Sector
- Healthcare
- Industry
- Pharmaceuticals
Returns
- Listing
- +42.6%
- 1 month
- +69.1%
- 3 months
- +71.6%
- 6 months
- +31.0%
- 1 year
- -14.9%
- Current (03 Nov 26)
- +203.9%
Financials · from the offer document, ₹ crore
| Period | Revenue | EBITDA | PAT | Net worth | Borrowings | Total assets |
|---|---|---|---|---|---|---|
| FY19 | 277.8 | 39.4 | 93.8 | 253.1 | ||
| FY20 | 311.6 | 73.4 | 149.2 | 336.4 | ||
| FY21 | 385.4 | 123.8 | 268.9 | 445.8 | ||
| 30 Sep 21 | 334.9 | 504.1 |
Reservation · share of the issue the offer document allocates to each category
- qib
- 75%
- nii
- 15%
- retail
- 10%
Subscription
| Category | Exchange | Times subscribed |
|---|---|---|
| nii | NSE | 76.21× |
| qib | NSE | 13.55× |
| retail | NSE | 27.46× |
| total | NSE | 33.17× |
Lead managers
AXIS CAPITAL LIMITED · ICICI Securities Limited